BioLineRx Ltd (BLRX)

[midastouch017]

BLRX is a make or break stock,
meaning depending on results:

Upcoming Expected Milestones

Final results from the Phase 3 GENESIS trial in SCM in the first half of 2021;

Preliminary results of the Phase 1b study in ARDS in the first half of 2021;

Initial results from Part 2 of the Phase 1/2a trial of AGI-134 in solid tumors in the second half of 2021;

If item 1 is a postive, the stock rockets!

GLTY